Observed early and late adverse events for DAH in children with comparison to reported results of paediatric Ross procedures, mechanical AVR and standard allograft implantation in children [17]
. | DAH (n = 143) . | Ross (n = 3468) . | Mechanical (n = 799) . | Allograft (n = 517) . |
---|---|---|---|---|
Early death (%) | 0.70 | 3.72 | 6.95 | 10.55 |
Early reintervention (%) | 4.90 | 4.69 | 4.20 | 2.83 |
Early stroke (%) | 0.0 | 0.76 | 1.45 | 0.52 |
Early pacemaker (%) | 2.10 | 3.17 | 3.37 | 2.13 |
Sum of early adverse events (%/year) | 7.61 | 12.34 | 15.97 | 16.02 |
Late mortality (%/year) | 0.40 | 0.51 | 0.99 | 1.38 |
Any reoperation/intervention (%/year) | 3.41 | 3.42 | 1.18 | 4.78 |
Endocarditis (%/year) | 0.27 | 0.37 | 0.34 | 0.34 |
Thromboembolism | 0 | 0.13 | 0.42 | 0.09 |
Valve thrombosis (%/year) | 0 | 0.19 | 0.33 | 0.11 |
Bleeding (%/year) | 0 | 0.09 | 0.32 | 0.09 |
Stroke/TIA (%/year) | 0.14 | 0.09 | 0.43 | 0.11 |
Sum of late events | 4.22 | 4.80 | 4.01 | 7.01 |
. | DAH (n = 143) . | Ross (n = 3468) . | Mechanical (n = 799) . | Allograft (n = 517) . |
---|---|---|---|---|
Early death (%) | 0.70 | 3.72 | 6.95 | 10.55 |
Early reintervention (%) | 4.90 | 4.69 | 4.20 | 2.83 |
Early stroke (%) | 0.0 | 0.76 | 1.45 | 0.52 |
Early pacemaker (%) | 2.10 | 3.17 | 3.37 | 2.13 |
Sum of early adverse events (%/year) | 7.61 | 12.34 | 15.97 | 16.02 |
Late mortality (%/year) | 0.40 | 0.51 | 0.99 | 1.38 |
Any reoperation/intervention (%/year) | 3.41 | 3.42 | 1.18 | 4.78 |
Endocarditis (%/year) | 0.27 | 0.37 | 0.34 | 0.34 |
Thromboembolism | 0 | 0.13 | 0.42 | 0.09 |
Valve thrombosis (%/year) | 0 | 0.19 | 0.33 | 0.11 |
Bleeding (%/year) | 0 | 0.09 | 0.32 | 0.09 |
Stroke/TIA (%/year) | 0.14 | 0.09 | 0.43 | 0.11 |
Sum of late events | 4.22 | 4.80 | 4.01 | 7.01 |
Ross results include right ventricular procedures.
AVR: aortic valve replacement; DAH: decellularized aortic homograft; TIA: Transient ischemic attack.
Observed early and late adverse events for DAH in children with comparison to reported results of paediatric Ross procedures, mechanical AVR and standard allograft implantation in children [17]
. | DAH (n = 143) . | Ross (n = 3468) . | Mechanical (n = 799) . | Allograft (n = 517) . |
---|---|---|---|---|
Early death (%) | 0.70 | 3.72 | 6.95 | 10.55 |
Early reintervention (%) | 4.90 | 4.69 | 4.20 | 2.83 |
Early stroke (%) | 0.0 | 0.76 | 1.45 | 0.52 |
Early pacemaker (%) | 2.10 | 3.17 | 3.37 | 2.13 |
Sum of early adverse events (%/year) | 7.61 | 12.34 | 15.97 | 16.02 |
Late mortality (%/year) | 0.40 | 0.51 | 0.99 | 1.38 |
Any reoperation/intervention (%/year) | 3.41 | 3.42 | 1.18 | 4.78 |
Endocarditis (%/year) | 0.27 | 0.37 | 0.34 | 0.34 |
Thromboembolism | 0 | 0.13 | 0.42 | 0.09 |
Valve thrombosis (%/year) | 0 | 0.19 | 0.33 | 0.11 |
Bleeding (%/year) | 0 | 0.09 | 0.32 | 0.09 |
Stroke/TIA (%/year) | 0.14 | 0.09 | 0.43 | 0.11 |
Sum of late events | 4.22 | 4.80 | 4.01 | 7.01 |
. | DAH (n = 143) . | Ross (n = 3468) . | Mechanical (n = 799) . | Allograft (n = 517) . |
---|---|---|---|---|
Early death (%) | 0.70 | 3.72 | 6.95 | 10.55 |
Early reintervention (%) | 4.90 | 4.69 | 4.20 | 2.83 |
Early stroke (%) | 0.0 | 0.76 | 1.45 | 0.52 |
Early pacemaker (%) | 2.10 | 3.17 | 3.37 | 2.13 |
Sum of early adverse events (%/year) | 7.61 | 12.34 | 15.97 | 16.02 |
Late mortality (%/year) | 0.40 | 0.51 | 0.99 | 1.38 |
Any reoperation/intervention (%/year) | 3.41 | 3.42 | 1.18 | 4.78 |
Endocarditis (%/year) | 0.27 | 0.37 | 0.34 | 0.34 |
Thromboembolism | 0 | 0.13 | 0.42 | 0.09 |
Valve thrombosis (%/year) | 0 | 0.19 | 0.33 | 0.11 |
Bleeding (%/year) | 0 | 0.09 | 0.32 | 0.09 |
Stroke/TIA (%/year) | 0.14 | 0.09 | 0.43 | 0.11 |
Sum of late events | 4.22 | 4.80 | 4.01 | 7.01 |
Ross results include right ventricular procedures.
AVR: aortic valve replacement; DAH: decellularized aortic homograft; TIA: Transient ischemic attack.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.